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Abstract 
COPD patients have reduced muscle glutamate which may contribute to an impaired response 
of oxidative metabolism to exercise. We hypothesised that prior glutamine supplementation 
would enhance 
2OV

peak, 
2OV

 at lactate threshold and speed pulmonary oxygen uptake 
kinetics in COPD.  13 patients (9 male, age 66 ± 5 years, mean ± SD) with severe COPD 
(Mean FEV1 0.88 ± 0.23 L, 33 ± 7 % predicted) performed on separate days ramp cycle-
ergometry (5-10 W.min
-1
) to volitional exhaustion and subsequently square-wave transitions 
to 80% estimated lactate threshold (LT) following consumption of either placebo (CON) or 
0.125g.kg bm
-1
 of glutamine (GLN) in 5 ml.kg bm
-1
 placebo.  Oral glutamine had no effect 
on peak or 
2OV

 at LT, {
2OV

peak: CON = 0.70 ± 0.1 vs. GLN = 0.73 ± 0.2 l.min
-1
; LT: CON 
= 0.57 ± 0.1 vs. GLN = 0.54 ± 0.1 l.min
-1
} or 
2OV

 kinetics {tau: CON = 68 ± 22 vs. GLN = 
68 ± 16 s}.  Ingestion of glutamine before exercise did not improve indices of oxidative 
metabolism in this patient group.  
 
Key words: chronic obstructive pulmonary disease, oxygen uptake kinetics, tricarboxylic 
acid cycle, glutamine, glutamate 
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1. Introduction 
During exercise, patients suffering from chronic obstructive pulmonary disease (COPD) 
show an enhanced production of lactate, phosphocreatine breakdown and lower blood pH 
during exercise as compared to healthy age-matched controls (Engelen et al., 2000b; 
Kutsuzawa et al., 1995; Maltais et al., 1998).  The skeletal muscles of such patients are 
characterised by a muscle fibre type shift toward a greater proportion of fast twitch fibres 
(Gosker et al., 2002; Maltais et al., 1999), a reduction in key oxidative enzymes such as 
citrate synthase (Maltais et al., 2000), adenine nucleotide loss (Steiner et al., 2005), enhanced 
muscle lactate concentration even at rest (Engelen et al., 2000b) and slowed pulmonary 
oxygen uptake kinetics during recovery from exercise (Okamoto et al., 2003).  Furthermore, 
an acute intervention to relieve intracellular metabolic inertia (dichloroacetate infusion), 
independent of oxygen delivery resulted in significant improvements in 
2OV

 peak and peak 
work rate during incremental exercise (Calvert et al., 2008).  Taken together, these data 
suggest that in addition to the dyspnoea associated with COPD, impaired oxidative 
metabolism (and thus increased reliance upon anaerobic metabolism) in the ambulatory 
muscles can help explain the exercise intolerance found with this disease.  
 
One explanation for this increased reliance upon anaerobic metabolism in COPD is the 
augmented delay (~300s) in the attainment of a steady state of oxygen uptake during the 
transition from rest to exercise (Chiappa et al., 2008; Puente-Maestu et al., 2001; Somfay et 
al., 2002) as compared to ~180s in healthy, untrained controls (Somfay et al., 2002).  The 
extent of this “metabolic inertia” dictates the magnitude of the oxygen deficit produced 
during the rest-exercise transition, which in turn determines the degree of reliance upon 
anaerobic metabolism and the production of potentially fatiguing milieu, i.e. increased 
inorganic phosphate and ADP, reduced ATP and phosphocreatine (Allen et al., 2008).  
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Indeed, an inverse relationship (r = -0.7) has previously been shown between the time 
constant of the kinetics of pulmonary oxygen uptake and the time to exhaustion at a constant 
workload in COPD (Chiappa et al., 2008). 
 
Candidate sites within the oxidative respiratory chain that might contribute to this metabolic 
inertia include the pyruvate dehyrogenase complex (PDC), electron transport chain, oxygen 
delivery and the tricarboxylic acid (TCA) cycle.  In COPD, a lag in the activation of the PDC 
(Calvert et al., 2008) and delivery of oxygen (Chiappa et al., 2008; Chiappa et al., 2009; 
Laveneziana et al., 2009; Palange et al., 1995) have both been shown to be limiting to 
oxidative metabolism during the transition from rest to exercise.  The tricarboxylic (TCA) 
cycle and its intermediates (TCAi) do not seem to limit oxidative metabolism during the 
transition from rest to exercise in healthy populations, (Bruce et al., 2001), however there is 
evidence that the TCAi may be a limiting factor for oxidative metabolism in COPD.   
 
During the transition from rest to exercise in healthy subjects there is a ~300% increase in the 
concentration of the TCAi within the first five minutes.  This anaplerosis of the TCA cycle is 
primarily determined by increased flux through the alanine aminotransferase reaction (Gibala 
et al., 1997), which requires glutamate and pyruvate, producing alanine and entering the TCA 
cycle at the level of -ketoglutarate.  In healthy populations, oxidative metabolism does not 
appear to be limited by TCAi pool size (Bruce et al., 2001); however TCAi pool expansion is 
impaired in COPD patients (Engelen et al., 2001) and is associated with a low concentration 
of glutamate in the resting muscle compared to healthy age-matched controls (Engelen et al., 
200a; Engelen et al., 2000b; Engelen et al., 2001).  Glutamate concentration determines flux 
through the alanine aminotransferase reaction (Bruce et al., 2001; Gibala et al., 2002; Gibala 
and Saltin, 1999).  It is therefore feasible that the reduced muscle glutamate concentration in 
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COPD inhibits flux through the alanine aminotransferase reaction, and thus anaplerosis, 
resulting in significant metabolic inertia and a consequent retarding of the rate of increase of 
oxidative metabolism during the transition to exercise. 
 
Ingested glutamine is rapidly absorbed causing a sharp rise in plasma glutamine 
concentration (Marwood and Bowtell, 2007).  In apparent contrast to glutamate ingestion 
(Darmaun et al., 1986; Matthews et al., 1993; Rutten et al., 2008), circulating glutamine is 
readily taken up by the skeletal muscle (Mittendorfer et al., 2001) and can be converted to 
glutamate via the enzyme glutaminase.  Therefore if low muscle glutamate concentration is 
inhibiting flux through the alanine aminotransferase reaction in COPD, increasing glutamine 
ingestion may reverse this effect.  Indeed glutamine ingestion has previously been shown to 
enhance the exercise-induced increase in the TCAi pool during the transition from rest to 
exercise in healthy subjects (Bruce et al., 2001).  However, in these healthy subjects for 
whom TCAi pool size is not limiting, additional expansion of the TCAi pool did not enhance 
oxidative metabolism. In contrast, COPD patients experience significant metabolic inertia 
and blunted TCAi pool expansion during exercise associated with reduced glutamate 
availability. We therefore hypothesise that glutamine ingestion and the resultant augmented 
TCAi pool expansion at the onset of exercise will enhance oxidative metabolism in COPD 
patients.  Therefore the aim of the present study was to determine whether prior glutamine 
ingestion enhances 2oV
 peak and 2oV  at lactate threshold during incremental exercise and 
speeds pulmonary oxygen uptake kinetics during constant load exercise. 
 
2. Method 
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2.1 Patients 
We recruited 13 COPD patients (9 male) with clinically and physiologically confirmed 
moderate to severe COPD, all of which completed the study.  All patients were ex-smokers, 
clinically stable (free from exacerbations for at least 3 months prior to the study) and not 
taking any oral steroids.  All patients gave written informed consent and the protocol was 
approved by the South Sefton Research Ethics Committee. 
 
2.2 Lung function 
One week prior to the first exercise tests, all patients underwent spirometry, measurement of 
lung volumes and measurement of lung diffusion (whole-body plethysmography, ZAN560, 
Oberthulba, Germany).  The equipment was calibrated according to the manufacturer’s 
instructions. Subjects were asked to omit short-acting bronchodilators for 8 hours, long-
acting beta-agonists for 12 hours and long-acting anti-cholinergics for 24 hours before 
testing. Subjects were asked not to consume caffeine containing drinks on the day of testing. 
All tests were performed in accordance with ATS/ERS testing criteria. 
 
2.3 Experimental Design 
Patients visited the laboratory on 4 – 6 occasions, completing a single exercise test each time 
on a cycle ergometer (Lode Corival, Groningen, The Netherlands).  Prior to each visit to the 
laboratory, patients were requested to maintain an overnight fast and to consume their 
habitual diet and refrain from strenuous physical activity and consuming alcohol or caffeine 
in the 48 h prior to each experiment.  One hour before exercise subjects consumed either 5 
ml.kg
-1
 of weak lemon flavoured cordial (ASDA, Leeds, UK) as a placebo (CON) or the 
same volume of placebo in which was dissolved 0.125g.kg
-1
 of glutamine (L-glutamine, 
Myprotein.com, UK), (GLN) in a double blind manner.  During all exercise tests and in the 5 
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minutes following exercise cessation, heart activity (12-lead ECG), blood pressure (manual 
auscultation), perceived exertion (10-point scale for leg fatigue and breathlessness, (Jack et 
al., 2004)), oxygen saturation of blood (pulse oximetry, Nonin 8500, Nonin Medical, USA), 
ventilation and gas exchange (Zan 600, Oberthulba, Germany) were monitored.  The Zan 600 
metabolic cart uses a pneumotachometer for measuring ventilation, in combination with 
amperometric solid electrolyte oxygen sensor and infra-red carbon dioxide sensor.  Capillary 
earlobe blood samples were also taken at rest, end-exercise and 4-min post exercise for 
determination of blood lactate concentration (Biosen C-line, EKF, Germany).   
 
2.4 Part (a): incremental exercise 
Patients completed two (one in each condition, the order randomly allocated) ramp 
incremental tests 3 – 7 days apart.  Ramp rate was at 5 or 10 W.min-1 (55 – 65 rpm) until 
volitional termination of exercise, the lower ramp rate being chosen for those patients with an 
FEV1 < 1 litre.  The 2OV

 at lactate threshold was estimated via the v-slope method with 
confirmatory data from the ventilatory equivalent and end-tidal pressure plots for oxygen 
uptake and carbon dioxide production (Beaver et al., 1986).  
2OV

peak was defined as the 
highest 30-s average at any stage during the test.   
 
2.5 Part (b): constant load exercise 
One week following completion of part (a), patients completed a number of constant load 
exercise transitions of six minutes in duration instigated from a 3-minute baseline of rest to a 
workload equivalent to 80% of the lactate threshold; cadence was maintained at 55 – 65rpm 
each time.  Patients completed 1 (six patients) or 2 (seven patients) transitions in each 
condition (the order of which was allocated randomly), with only one exercise transition per 
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day.  All testing for part (b) was completed within 10 days.  Patients conducted an equal 
number of each type of exercise test in each condition (i.e. placebo or glutamine ingestion).   
 
2.6 Oxygen uptake kinetics  
Since exercise was undertaken at an intensity below the lactate threshold, pulmonary oxygen 
uptake kinetics during constant load exercise were assumed to proceed via single exponential 
term (fundamental phase) following a delay relative to the start of exercise: 
)1(* 2
222
/)(
)()(
VoTDt
VobOtO eAVV


   
 
The delay term accounts for the transit time of deoxygenated blood from the peripheral 
muscles to the lungs (cardiodynamic phase); data within this phase were removed from the 
dataset prior to the modelling process.  )(2 bOV

 is the oxygen uptake measured in the last 
minute of rest,
2Vo
A  is the asymptotic amplitude of the fundamental component of the 
response, 
2Vo
 is the time constant of the fundamental component and TD is a time delay 
similar, but not equal to the cardiodynamic-fundamental phase transition time (which is 
defined as 
2Vo
TD ).  Steady state oxygen uptake ( )(2 ssOV

) is therefore the sum of )(2 bOV

 and 
2Vo
A .  To give an indication of the overall kinetic response to exercise, the mean response 
time (
2VO
MRT ) was calculated as 
2Vo
TD  + 
2Vo
 .   
 
To prepare the data for the modelling process, abnormal breaths due to coughs and swallows 
were first removed from the data so as not to skew the underlying response.  The criterion for 
removal of these breaths was those that were different to the mean of the surrounding four 
data points by more than three times the standard deviation of those four points (Brittain et 
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al., 2001).  Data were then interpolated second-by-second; when more than one transition was 
completed for a given condition (i.e. placebo or glutamine) the datasets were ensemble 
averaged to yield a single response for that condition. The end of the cardiodynamic phase 
(
2Vo
TD ) was evaluated by (i) observing the point at which there was a sharp fall in end-tidal 
pressure of O2 and RER (Whipp and Ward, 1990) coincident with (ii) the time-point 
displaying a plateau or minima for the value of  and a minima for the reduced chi-square 
value when the start of the fitting window was incrementally from 0 s up to 60 s.  Custom 
written software in Microsoft Excel, using the Solver function, was utilised for all modelling 
processes, an example of which is provided in figure 1.   
 
2.7 Statistics   
All values are presented as mean  standard deviation, with differences between conditions 
evaluated by a paired sample t-test.  Relationships between variables were assessed via a 
Pearson correlation with statistical significance accepted at P ≤ 0.05. 
 
3. Results 
3.1 Patients 
Table 1 shows patient characteristics including resting lung function data.  The static lung 
function results suggest that the patient group had significant airflow obstruction as shown by 
FEV1 and FEV1/FVC data, pulmonary hyperinflation as shown by total lung capacity (TLC) 
and residual volume (RV) data with evidence of emphysema as shown by the diffusing 
capacity of the lung for carbon monoxide (DLCO) and carbon monoxide transfer coefficient 
(KCO) data. 
 
3.2 Part a: incremental exercise 
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Glutamine ingestion had no effect on the 
2OV

 at lactate threshold (CON: 0.57 ± 0.1 vs GLN: 
0.54 ± 0.1 l.min
-1
), 
2OV

peak (CON: 0.70 ± 0.1 vs GLN: 0.73 ± 0.2 l.min
-1
) or peak work-rate 
achieved (CON: 39 ± 17 vs GLN: 42 ± 18 W).  There was also no effect of glutamine 
ingestion on resting (CON: 1.1 ± 0.3 vs GLN: 1.0 ± 0.3 mmol.l.
-1
), end- (CON: 2.3 ± 0.8 vs 
GLN: 2.2 ± 0.9 mmol.l.
-1
), or post-exercise (CON: 2.2 ± 0.8 vs GLN: 2.6 ± 1.3 mmol.l.
-1
), 
blood lactate concentration.  At the termination of exercise, blood oxygen saturation (CON: 
90 ± 4 vs GLN: 90 ± 4 %), ratings of perceived leg exertion (CON: 5.5 ± 2.7 vs GLN: 5.4 ± 
3.2) and ratings of perceived breathlessness (CON: 6.4 ± 1.9 vs GLN: 7.2 ± 2.4) were not 
different between trials.  
 
3.3 Part b: constant load exercise 
A representative plot of the oxygen uptake response to constant load exercise is shown in 
figure 2.  The confidence interval of 
2Vo
  was 6.9 ± 2.0 s in CON and 7.4 ± 3.4 s in GLN 
(CON: 11.4 ± 4.9 vs 11.5 ± 4.8, expressed as % of 
2Vo
 ).  When comparing the 6 patients 
who completed two transitions in each condition with the remaining 7 who completed just 
one, there did not appear to be any significant narrowing of these confidence intervals (CON: 
6.9 ± 2.2 vs 6.8 ± 2.0 s; GLN: 6.6 ± 2.0 vs 8.1 ± 4.3 s or CON: 10.4 ± 2.7 vs 12.3 ± 6.4; 
GLN: 10.7 ± 3.2 vs GLN: 12.1 ± 6.1 expressed as % of 
2Vo
 ; two transition vs one transition, 
respectively).  There was no relationship between markers of the extent of airflow 
obstruction, emphysema or pulmonary hyperinflation and
2Vo
 , its confidence interval or 
2VO
MRT .  The only exception to this was a significant relationship between the absolute total 
lung capacity and the 95% confidence interval for 
2Vo
  (r = 0.74, P < 0.01) indicating that 
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~54% of the variation in the 95% confidence interval of 
2Vo
 could be explained by absolute 
total lung capacity. 
 
Glutamine ingestion had no effect on either the time-constant or mean response time of 
oxygen uptake kinetics (table 2) or subjective indicators of fatigue (table 2).  There was also 
no effect of glutamine ingestion on resting or end-exercise blood lactate concentration or 
blood oxygen saturation (table 2).   
 
4. Discussion 
The main finding of the present study was that glutamine ingestion prior to exercise conferred 
no beneficial effect on oxidative metabolism or performance during incremental and constant 
load exercise in COPD. Peak work-rate, peak oxygen uptake, oxygen uptake at lactate 
threshold and oxygen uptake kinetics were all unchanged following prior glutamine ingestion 
as compared to placebo.  Given these findings it is therefore unsurprising that blood lactate 
concentration and subjective indicators of fatigue were also unaffected by glutamine 
ingestion. 
 
Potential sites within the oxidative respiratory chain that may contribute to metabolic inertia 
at the onset of exercise, in both health and disease include oxygen delivery, the electron 
transport chain, the PDC and the TCA cycle.  Enhancing oxygen delivery through hyperoxia 
has been demonstrated to enhance performance during maximal incremental exercise in 
healthy subjects (Prieur et al., 2002), and during high intensity constant load exercise in both 
healthy subjects and COPD (Siqueira et al., 2010; Wilkerson et al., 2006).  Whilst such 
interventions have no effect on the fundamental phase of pulmonary oxygen uptake kinetics 
in healthy subjects, (Hughson and Kowalchuk, 1995; Wilkerson et al., 2006), this has been 
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shown to be speeded by hyperoxia and heliox in COPD (Chiappa et al., 2009; Palange et al., 
1995).  Infusion of L-NAME speeded pulmonary oxygen uptake kinetics at the onset of 
moderate and heavy exercise in healthy subjects, possibly by relieving inhibition of enzymes 
in the electron transport chain (Jones et al., 2003; Jones et al., 2004a); such studies have not 
however been replicated in COPD.  Activation of the PDC prior to exercise via DCA infusion 
has on a number of occasions been shown to reduce the muscle lactate accumulation and 
phosphocreatine degradation during subsequent constant load exercise, suggesting a role of 
the PDC in determining intracellular metabolic inertia (Howlett et al., 1999; Timmons et al., 
1998a; Timmons et al., 1998b).  Despite these findings, a number of studies have found no 
effect of DCA infusion on the fundamental time constant of pulmonary oxygen uptake 
kinetics at the onset of exercise (Koppo et al., 2004; Jones et al., 2004b; Marwood et al., 
2010; Rossiter et al., 2003).  During incremental exercise, it was recently demonstrated that 
DCA infusion enhanced peak 
2OV

 and work rate in COPD (Calvert et al., 2008).  
Importantly, this effect of DCA infusion during incremental exercise was not replicated in 
healthy subjects (Wilkerson et al., 2009), demonstrating that the effects of a given 
intervention on intracellular inertia may be apparently small in healthy subjects, but 
significant in certain diseased populations.  The present study is the first to examine the 
potential for the TCAi pool size to confer a limiting role in COPD patients. Whilst there is 
little evidence in healthy subjects to suggest that the rate and magnitude of the exercise-
induced increase in the TCAi at the onset of exercise is limiting to oxidative metabolism 
(Bowtell et al., 2007), the above discussion demonstrates how findings in healthy subjects 
can rarely be applied to diseased populations such as COPD without experimental 
confirmation.   
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In contrast to healthy subjects, anaplerosis of the TCA cycle is apparently impaired in COPD 
during exercise since Engelen et al., (Engelen et al., 2001) showed no change in muscle 
succinate (one of the TCAi) concentration and a 5% fall in muscle alanine concentration 
(indicative of impaired flux through the primary anaplerotic reaction, alanine 
aminotransferase).  The concentration of glutamate appears to be the most important factor in 
determining flux through the alanine aminotransferase reaction (Bruce et al., 2001; Gibala et 
al., 2002; Gibala and Saltin, 1999).  The very low muscle glutamate content seen at rest in 
COPD as compared to healthy controls (Engelen et al., 2000a; Engelen et al., 200b; Engelen 
et al., 2001) therefore suggests impairment of TCA cycle anaplerosis in COPD due to low 
muscle glutamate concentration, and thus a potential mechanism by which oxidative 
metabolism is inhibited.  It has previously been shown that glutamine ingestion prior to 
exercise results in an enhancement of the exercise induced increase in the TCAi pool (Bruce 
et al., 2001).  In the present study, glutamine ingestion was therefore used as a means by 
which to mitigate a chronically low muscle glutamate concentration, and thus enhance the 
exercise-induced increase in the TCAi pool, in an attempt to reduce some of the significant 
metabolic inertia which exists in COPD.  However as previously demonstrated in healthy 
subjects (Bruce et al., 2001; Marwood and Bowtell, 2007; Marwood and Bowtell, 2008), in 
the present study glutamine ingestion had no effect on the measured indices of oxidative 
metabolism suggesting either that glutamine ingestion did not impact upon TCA cycle 
anaplerosis or that the normal rate and magnitude of the increase of the TCAi during exercise 
is not limiting to oxidative metabolism in COPD. 
 
Though we replicated the glutamine ingestion protocol of Bruce et al. (Bruce et al., 2001), the 
present study was limited by not confirming its intended effects either by measuring muscle 
TCAi (Bruce et al., 2001) or plasma (Marwood and Bowtell, 2007) glutamine concentrations.  
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However, a previous study with a similar patient group showed no difference in the plasma 
glutamine response to glutamine ingestion as compared to healthy controls (Rutten et al., 
2006).  Therefore it seems unlikely that the sharp rise in plasma glutamine concentration as 
seen in previous, identical glutamine ingestion regimes (Marwood and Bowtell, 2007) did not 
occur.  Since the Km of glutamine transport in human skeletal muscle is close to normal 
plasma glutamine concentration (Ahmed et al., 1993), glutamine uptake by the muscle is 
primarily dependent upon extracellular glutamine concentration.  There is no evidence to 
suggest that either the system Nm amino acid transporter or glutaminase activity are 
adversely affected in this patient group.  However, it is plausible that intramuscular alanine 
aminotransferase activity is reduced in COPD since this has been shown in the sera of COPD 
as compared to healthy controls (Cepelak et al., 2006).  Though unlikely, it is possible 
therefore that glutamine ingestion did not result in TCAi pool expansion as previously 
observed in controls (Bruce et al., 2001) since we were unable to experimentally confirm this.  
 
Assuming that glutamine ingestion did result in an enhancement of the exercise-induced 
increase in the TCAi pool, then we can conclude that the normal rate and magnitude of the 
changes in the TCAi pool are not limiting oxidative metabolism during exercise in COPD.  
However any increase in the capacity for TCA cycle flux provided for by glutamine ingestion 
necessitates a concomitant increase in oxygen delivery to oxidise the additional NADH and 
FADH2.  Hence, manipulations of the TCAi alone, may serve only to exacerbate the oxygen 
delivery limitation that exists within this patient group, (Chiappa et al., 2008; Chiappa et al., 
2009; Laveneziana et al., 2009; Palange et al., 1995), with no overall effect on oxidative 
metabolism.  In other words, interventions to enhance oxidative metabolism may only be 
effective if they relieve inhibition at multiple limiting sites in the respiratory chain, e.g. 
glutamine ingestion combined with hyperoxia or heliox.  In addition to this possibility, the 
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methods used to assess oxidative metabolism deserve some discussion as to their suitability 
to detect alterations in oxidative metabolism due to glutamine ingestion. 
 
The indirect methods used in the present study to measure the impact of glutamine ingestion 
on indices of oxidative metabolism have previously been shown to be sufficiently sensitive to 
detect changes reflecting improvements to oxidative metabolism in this patient group.  For 
example, the lactate threshold, peak work rate, peak oxygen uptake and oxygen uptake 
kinetics have all been shown to be improved in COPD patients following both acute, e.g.  
dichloroacetate infusion (Calvert et al., 2008), heliox (Chiappa et al., 2009) and hyperoxia 
(Palange et al., 1995) and chronic, e.g. training (Casaburi et al., 1997; Coppoolse et al., 1999; 
Franssen et al., 2004; Ortega et al., 2002; Otsuka et al., 1997; Vogiatzis et al., 2005) 
interventions designed to enhance the capability of oxidative metabolism .  Consequently the 
present data suggest no effect of glutamine ingestion on 
2OV

peak, 
2OV

 at lactate threshold 
and pulmonary oxygen uptake kinetics in COPD.  Based on the proposed effects of glutamine 
ingestion, we therefore suggest that the rate and magnitude of anaplerosis of the TCA cycle at 
the onset of exercise is not limiting to oxidative metabolism in COPD.  Whether this remains 
the case in the presence of interventions which can enhance oxygen delivery, (e.g. hyperoxia, 
heliox), remains to be elucidated. 
 
Perhaps the parameter around which most uncertainty can arise is that of the time constant of 
oxygen uptake kinetics.  The confidence by which pulmonary oxygen uptake kinetics can be 
modelled is dependent on the amplitude of the response, number of exercise transitions and 
the “noise” in the breath-by-breath data (Lamarra et al., 1987).  Hence type 2 errors can 
easily occur if wide confidence intervals do not allow discrimination between “real” effects 
of the imposed intervention.  In the present study, the amplitude of the response was 
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relatively low (~0.4 L), reflecting the low-work rate at lactate threshold, and only one or two 
transitions were completed in each condition.  However, COPD patients do not possess 
greater breath-to-breath noise than healthy subjects (Puente-Maestu et al., 2002), suggesting 
that the severity of airflow does not impact upon the confidence of the modelled parameters; 
although in the present study there appeared to be a weak relationship between total lung 
capacity (an index of pulmonary hyperinflation) and the 95% confidence interval of the time 
constant of pulmonary oxygen uptake kinetics (r=0.74).  More importantly, the 95% 
confidence interval for the time constant of oxygen uptake kinetics we observed  (~11 – 12% 
of the mean) is more than acceptable (Fawkner et al., 2002) and is an improvement on 
previous studies in COPD (Palange et al., 1995).  We are therefore confident of the modelling 
process, and together with the similarity of the mean value of this parameter between 
conditions, it seems unlikely a type 2 error occurred; rather the oxygen uptake kinetic data 
supports the blood lactate and perceived exertion data during constant load exercise and the 
2OV

peak, peak work-rate and 
2OV

 at lactate threshold data during incremental exercise, all 
showing no effect of glutamine ingestion on oxidative metabolism in COPD. 
 
In summary, the present study showed no effect of glutamine ingestion on aerobic function 
during incremental or constant load exercise in COPD.  We used glutamine ingestion as a 
means to mitigate the chronically low muscle glutamate concentration in this patient group 
and enhance flux through the alanine aminotransferase reaction, thus reducing metabolic 
inertia at the level of the TCA cycle.  Based on this hypothesis the data therefore suggest that 
TCA cycle anaplerosis is not limiting for oxidative metabolism during exercise in COPD 
patients.   
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Figure Captions 
Figure 1. Determination of the end of the cardiodynamic phase of pulmonary oxygen uptake 
kinetics.  Vertical line represents the point in time where a sharp drop in RER and the end-
tidal pressure of O2 coincides with a plateau or minima for the value of  and a minima for 
the reduced chi-square value 
 
Figure 2. Representative plot of pulmonary oxygen uptake kinetics with exponential curve fit 
and residuals shown; in this example a placebo trial is shown 
 
Table Captions 
Table 1.  Baseline characteristics of patients 
 
Table 2. Parameters of constant load exercise in the placebo (CON) and glutamine ingestion 
(GLN) conditions 
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